Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Mur d'écrans de télévision

Press Room

Resources dedicated to journalists and media professionals

The PR department responds to all media requests for information on scientific, medical, technological and entrepreneurial activities at Paris Brain Institute.

It disseminates new results from research teams and connects journalists to a relevant expert to comment on a current issue.

Feel free to contact our press officer to help you develop a topic that relies on state-of-the-art knowledge in neuroscience, neurology or psychiatry.

Press contact
Marie Simon
Email : presse@icm-institute.org

Our press documents

La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
Serge Weinberg © Simon Cassanas
Serge Weinberg appointed Chairman of Paris Brain Institute Board of Directors
Paris Brain Institute announces Serge Weinberg’s election as President of its Board of Directors. He succeeds Gérard Saillant, our Founding President, who becomes Honorary President after fifteen years of dedicated service to the Institute.
10.16.2025 Institutional
lauréat de la 3ème édition de l’appel à projets NeurAL
Brahim Nait Oumesmar, winner of the 3rd NeurAL call for projects
This year, NeurAL, Paris Brain Institute’s start-up studio, has selected a project by the researcher Brahim Nait Oumesmar that seeks to develop a remyelinating treatment for multiple sclerosis. The winner will benefit from personalized support and...
10.15.2025 Research applications
Organoïde de cerveau. Crédit : Wellcome Images.
Launch of the Brain Fund II, a private equity fund for the benefit of Paris Brain Institute, with a target of €30 million
The Brain Fund II, a private equity fund managed by Impact Partners, aims to provide Paris Brain Institute with permanent financial resources to support the projects of research teams.
08.28.2025 Support
La bibliothèque de Babel
Mental Time Travel: A New Case of Autobiographical Hypermnesia
Remembering past events in minute detail, revisiting them methodically, and reliving past emotions—this is the peculiarity of people with an exceptional memory of their own lives, known as autobiographical hypermnesia, or hyperthymesia. This...
08.28.2025 Research, science & health
Crédit : Ana Yael.
An International Database to Better Understand Dreams
In an article published in Nature Communications, researchers from 37 scientific institutions—including Paris Brain Institute—unveil the DREAM database: an ambitious project designed to centralize, share, and standardize data from research on sleep...
08.14.2025 Research, science & health
Le cortex moteur
Origin of Lance-Adams Syndrome Finally Elucidated
First described 60 years ago, chronic myoclonus following cerebral anoxia is now known as Lance-Adams syndrome. This is a severe disorder whose mechanisms were, until now, poorly understood. Geoffroy Vellieux, Vincent Navarro, and their colleagues at...
06.16.2025 Research, science & health
Tiré de New Theory of Colours de Mary Gartside, 1808
Aphantasia Might Be Linked to Alterations in Brain Connectivity
Thanks to 7T fMRI, researchers from Paris Brain Institute and NeuroSpin, the CEA's neuroimaging centre, are exploring the neural substrate of visual imagery at very high resolution for the first time. Their results, publiés [i] in Cortex, pave the...
06.06.2025 Research, science & health
Un nouveau-né
NewBorn Neurodigital Project Highlighted at AI Action Summit
On the occasion of the Summit for Action on Artificial Intelligence (AI), which took place on 10 and 11 February 2025 in Paris, France welcomed representatives of some 100 countries, including many heads of state, business leaders, researchers and...
02.14.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health

Our useful documents

All

No results found

RA2024
Annual Report 2024
08.08.2025
La première page du RA 2023
Annual Report 2023
09.13.2024

News that might interest you

Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
Julien SERUSCLAT
Julien Serusclat: effective writing for clinical trials
As a medical writer within the Neurotrials team, Paris Brain Institute’s early clinical development unit, Julien Serusclat uses his writing skills for the benefit of the scientific community. He develops the essential documents used in clinical...
11.05.2025 Portraits
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
lauréat de la 3ème édition de l’appel à projets NeurAL
Brahim Nait Oumesmar, winner of the 3rd NeurAL call for projects
This year, NeurAL, Paris Brain Institute’s start-up studio, has selected a project by the researcher Brahim Nait Oumesmar that seeks to develop a remyelinating treatment for multiple sclerosis. The winner will benefit from personalized support and...
10.15.2025 Research applications
Serge Weinberg © Simon Cassanas
Serge Weinberg appointed Chairman of Paris Brain Institute Board of Directors
Paris Brain Institute announces Serge Weinberg’s election as President of its Board of Directors. He succeeds Gérard Saillant, our Founding President, who becomes Honorary President after fifteen years of dedicated service to the Institute.
10.16.2025 Institutional
See all our news